Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

Bayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its ...

However, advancements are extending its utility far beyond imaging, offering innovative functionalities that support and ...

Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic ...

MRI scan centre at MGMGH in Tiruchi sees increased patient capacity, reduced wait times, and faster report turnaround.

Bayer seeks US FDA approval for contrast agent, gadoquatrane for contrast-enhanced MRI of the CNS and other body regions: Berlin Wednesday, June 18, 2025, 09:00 Hrs [IST] Bayer an ...

Coherent Corp. (NYSE: COHR), a global leader in photonics, introduces the LEAP 600C, the industry’s first 600 W class excimer ...

Delhi govt has decided to hire a consultant to work out the modalities for commissioning and operating radiological ...

Intracranial aneurysms are common, and the risk of rupture is influenced by size, location, morphology, and factors such as ...

Physicists develop efficient alternatives to the classic Halbach design – with potential for a wide range of applications ...

Tiarna Lee explores the root causes of racial bias in AI-driven cardiac imaging to support the development of fairer, more ...